InvestorsHub Logo
icon url

Amatuer17

06/14/16 7:52 AM

#3435 RE: TheBioTechG #3433

Thanks

"
After ending the alternative treatment – which Sheen calls "a more dubious trail" – he admits he was "a little bit leery" of other new forms of treatment. But, he says he is currently on the eighth week of a 14-week FDA-approved test trial of a new drug called PRO 140 from the company CytoDyn.

"It's one shot a week that they're actually moving towards having bi-monthly and then, ultimately, just once a month. But the test I'm in now is once a week, and there's no side effects," says Sheen.

While Sheen says the traditional drug cocktail kept him healthy and safe, it led to "a lot of stomach problems, migraines, a disconnect – like a petite form of dementia, at times, not really knowing where you were; what was going on at the time – and it created a depression."

Sheen calls PRO 140 a "game-changer" because of the "manageable" dosage it requires. "You're not saddled with the reminder every day: [When] you've gotta take your pills, you're reminded; there's a whole psychological aspect to that."